We found that higher GFI1 levels increase MM cell growth and viability and enhance MM cell resistance to bortezomib-induced cell death in vitro, and also increases MM cell growth and MM-induced osteoclastogenesis in vivo (163). This evidence concerns the gene GFI1 and Miyoshi myopathy.